Cargando…

Relationship between immune gene signatures and clinical response to PD-1 blockade with pembrolizumab (MK-3475) in patients with advanced solid tumors

Detalles Bibliográficos
Autores principales:	Ayers, Mark, Lunceford, Jared, Nebozhyn, Michael, Murphy, Erin, Loboda, Andrey, Albright, Andrew, Cheng, Jonathan, Kang, S Peter, Ebbinghaus, Scot, Yearley, Jennifer, Shankaran, Veena, Seiwert, Tanguy, Ribas, Antoni, McClanahan, Terri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645163/ http://dx.doi.org/10.1186/2051-1426-3-S2-P80

Ejemplares similares

Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)
por: Hodi, F Stephen, et al.
Publicado: (2014)

Preclinical to clinical translation of anti-PD-1 blockade
por: Hirsch, Heather, et al.
Publicado: (2015)

Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types
por: Cristescu, Razvan, et al.
Publicado: (2022)

An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013
por: Ribrag, Vincent, et al.
Publicado: (2015)

Pembrolizumab (MK-3475) in combination with lenalidomide and low-dose dexamethasone for relapsed/refractory multiple myeloma (RRMM): KEYNOTE-023
por: Mateos, Maria-Victoria, et al.
Publicado: (2015)

A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancer
por: Baretti, Marina, et al.
Publicado: (2023)

Clinical applications of PD-1-based therapy: a focus on pembrolizumab (MK-3475) in the management of melanoma and other tumor types
por: Gangadhar, Tara C, et al.
Publicado: (2015)

Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors
por: Shimizu, Toshio, et al.
Publicado: (2016)

Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087
por: Chen, Robert, et al.
Publicado: (2015)

Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041)
por: Yamazaki, Naoya, et al.
Publicado: (2017)

Pembrolizumab
por: Khoja, Leila, et al.
Publicado: (2015)

Biomarkers predictive of response to pembrolizumab in head and neck cancer
por: Pfister, David G., et al.
Publicado: (2022)

Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma
por: Haddad, Robert I, et al.
Publicado: (2022)

Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors
por: Cristescu, Razvan, et al.
Publicado: (2022)

Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006
por: Hamid, Omid, et al.
Publicado: (2018)

Pembrolizumab Utilization and Outcomes for Advanced Melanoma in US Community Oncology Practices
por: Cowey, C. Lance, et al.
Publicado: (2018)

A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma
por: Dummer, Reinhard, et al.
Publicado: (2015)

3475 A TL1 Team Approach to CNS-Localized Delivery of Neurotrophic Factors for Treatment of Parkinson’s Disease
por: Gopinath, Adithya, et al.
Publicado: (2019)

Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC
por: Garassino, Marina C., et al.
Publicado: (2022)

Effects of the addition of leucine on flavor and quality of sausage fermented by Lactobacillus fermentum YZU-06 and Staphylococcus saprophyticus CGMCC 3475
por: Liu, Rui, et al.
Publicado: (2023)

Tuberculosis from a Dental Standpoint
por: McClanahan, A. A.
Publicado: (1912)

Report of Two Cases of Typhoid Fever
por: McClanahan, J. M.
Publicado: (1899)

Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
por: Wang, Meihua, et al.
Publicado: (2019)

Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukemia - Still a Valid Treatment Option, or is the Game Over?
por: McClanahan, Fabienne, et al.
Publicado: (2012)

Tinea corporis in a wrestling team cheerleader()
por: McClanahan, C., et al.
Publicado: (2016)

Conspecific recognition of pedal scent in domestic dogs
por: McClanahan, Kari, et al.
Publicado: (2020)

New Frontiers: The Role of CAR T-Cell Therapy in Multiple Myeloma
por: McClanahan, Alli, et al.
Publicado: (2022)

Vitamin D status among patients visiting a tertiary care center in Riyadh, Saudi Arabia: a retrospective review of 3475 cases
por: Alfawaz, Hanan, et al.
Publicado: (2014)

Assessing Gear Modifications Needed to Optimize Yields in a Heavily Exploited, Multi-Species, Seagrass and Coral Reef Fishery
por: Hicks, Christina C., et al.
Publicado: (2012)

A titration model for evaluating calcium hydroxide removal techniques
por: PHILLIPS, Mark, et al.
Publicado: (2015)

Navigating Adolescence with a Chronic Health Condition: A Perspective on the Psychological Effects of HAIR-AN Syndrome on Adolescent Girls
por: McClanahan, Kimberly K., et al.
Publicado: (2006)

Dimensionality analysis of forearm muscle activation for myoelectric control in transradial amputees
por: McClanahan, Alexander, et al.
Publicado: (2020)

Qualitative Assessment of Fire Station Food Environment Using Photovoice
por: McClanahan, Kristen, et al.
Publicado: (2022)

Reverse Translating Molecular Determinants of Anti–Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models
por: Georgiev, Peter, et al.
Publicado: (2022)

Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program
por: Gangadhar, Tara C., et al.
Publicado: (2017)

Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D(3) Receptor Blockade
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2017)

Mitigating the Morbidity of Financial Toxicity in Cancer Care
por: Shankaran, Veena
Publicado: (2021)

Molecular targeted therapies in head and neck cancer - An update of recent developements -
por: Goerner, Martin, et al.
Publicado: (2010)

Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial
por: Shitara, Kohei, et al.
Publicado: (2023)

Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model
por: Yang, Bangkun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gfvlmcq3gm6abolc7ldio5ne2j